You are here

Article Text

Article menu
Download PDFPDF
How to understand it
Genomic testing in neurology
  1. Vani Jain,
  2. Rachel Irving,
  3. Angharad Williams
  1. All Wales Medical Genomics Service, University Hospital of Wales Healthcare NHS Trust, Cardiff, UK
  1. Correspondence to Dr Vani Jain, All Wales Medical Genomics Service, University Hospital of Wales Healthcare NHS Trust, Cardiff CF14 4XW, UK; vani.jain{at}wales.nhs.uk

Abstract

Genomic testing has been available for neurological conditions for decades. However, in recent years, there has been a significant change in its availability, range and cost, as well as improvements in the technology and knowledge that underpin how the genome is interrogated. Neurologists can encounter a wide range of genetic conditions, and so their understanding of genomic testing is fundamental to modern clinical practice.

  • genetics
  • neurogenetics

Data availability statement

Data sharing not applicable as no datasets generated and/or analysed for this study.

https://doi.org/10.1136/pn-2023-003735

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Data availability statement

    Data sharing not applicable as no datasets generated and/or analysed for this study.

    View Full Text

    Footnotes

    • Contributors VJ wrote and revised the article. RI and AW reviewed and revised the article.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Commissioned. Externally peer reviewed by Ed Newman, Glasgow, UK, and Helen Grote, London, UK.